Dataset on cost-analysis of medication deprescribing scenarios for older adult coverage under public drug benefit programs in Canada

• Published in: Data in brief 2020-08, Vol.31, p.105842-105842, Article 105842
• Main Authors: Fadaleh, Sarah Abu, Shkrobot, Jody, Makhinova, Tatiana, Eurich, Dean, Sadowski, Cheryl A.
• Format: Article
• Language: English
• Subjects: Costs and cost analysis; Deprescriptions; Drug costs; Inappropriate prescribing; Pharmacology, Toxicology and Pharmaceutical Science; Pharmacy economics; Pharmacy fee
• ISSN: 2352-3409; 2352-3409
• DOI: 10.1016/j.dib.2020.105842

The dataset covers the equations and procedure used for the estimation of an older adult's total annual medication costs, across Canadian provinces and territories; detailed to report pharmacy margin, government share, and patient share. We presented a case of an older adult using 10 different medications commonly used, according to Canadian Institute for Health Information. Eight different deprescribing scenarios were created, based on recommendations from Beers Criteria and the Canadian Deprescribing Network, for the purpose of comparing the cost difference before and after each intervention on pharmacies, patients, and governments. Scenarios included: (1) Stopping an over the counter medication; (2) Discontinuation of a medication; (3) Slow taper of a potentially inappropriate medication; (4) Rapid taper of a potentially inappropriate medication; (5) Switching to safer medication; (6) Dose reduction; (7) Switching to a lower cost medication; (8) Changing from combination to a single medication. The data presented are related to the article entitled “Financial advantage or barrier when deprescribing for seniors: A case based analysis” [1]